User:Michael Strong/TB
Web Supplement to:
Comprehensive Structural Analysis of Drug-Resistant Mutations in Mycobacterium tuberculosis.
Michael Strong 1,2, Andreas Sandgren 3,4, James E. Galagan 5,6, Mark Borowsky 5,7,8, George M. Church 2, Megan B. Murray 3,
1.Center for Genes, Environment, and Health, National Jewish Health, Denver, CO, 80206,
2.Department of Genetics, Harvard Medical School, Boston, MA 02115,
3.Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115,
4.European Centre for Disease Prevention and Control,
5.Broad Institute of MIT and Harvard, Cambridge, MA, 02142,
6.College of Engineering, Boston University, Boston, MA, 02118,
7.Department of Molecular Biology, Massachusetts General Hospital, Boston, MA, 02114,
8.Department of Genetics, Massachusetts General Hospital, Boston, MA, 02114.
Correspondence regarding this webpage can be sent to: StrongM@NJHealth.org
Please click on the GREEN links to see the structural details described.
RpoB homology model with Rifampin boundRpoB homology model with Rifampin bound
|
GidB homology model with S-adenosylmethionine boundGidB homology model with S-adenosylmethionine bound
|
RpsL homology model with streptomycinRpsL homology model with streptomycin
|
InhA crystal structure with ETH-NAD boundInhA crystal structure with ETH-NAD bound
|
InhA crystal structure with INH-NAD boundInhA crystal structure with INH-NAD bound
|
GyrA crystal structureGyrA crystal structure
|
KatG crystal structure with heme boundKatG crystal structure with heme bound
|
PncA crystal structurePncA crystal structure
|